论文部分内容阅读
γ-谷氨酰转移酶(gamma-glutamyl transferase,GGT)对急性冠状动脉综合征(acute coronary syndromes,ACS)患者的预后价值尚不清楚。研究人员针对这一临床相关问题,连续入选行经皮冠状动脉介入(percutaneous coronary intervention,PCI)治疗的ACS患者2534例,进行调查。所有受试者在PCI前
The prognostic value of γ-glutamyl transferase (GGT) in patients with acute coronary syndromes (ACS) remains unclear. In response to this clinically relevant issue, the researchers conducted a series of 2534 ACS patients consecutively enrolled in percutaneous coronary intervention (PCI). All subjects before PCI